Biotechnology

Play
Biotech

Watch: How biotech startups become unicorns, explained

By Damian Garde

Lots of people
Biotech

How Colorado firefighters, a Hawaiian charity, and TV writers are fueling the biotech boom

By Kate Sheridan

Play
The Readout LOUD

Listen: Relitigating Vioxx, industry growing pains, & how biotech VC works

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Biotech

Archived chat: An online discussion about the Q4 biotech scorecard

By Adam Feuerstein

Courtesy Julia Vitarello
Biotech

After a bespoke therapy rescues a young girl, the FDA considers advance of individualized treatments

By Meghana Keshavan

Pharmalot

A small biotech raises the price on its cancer drug by 20% this year, but will anyone notice?

By Ed Silverman

Frances Arnold
Politics

With a new lobbying group and a day at the White House, synthetic biology looks for footing in Washington

By Nicholas Florko and Rebecca Robbins

Adam's Take

A cancer company has misled investors repeatedly about its drug. It’s time for some truth-telling

By Adam Feuerstein

Nobel Prize Medal
Biotech

These 4 biotechs are already bragging about their ‘Nobel Prize-winning’ bona fides

By Kate Sheridan

Sarepta - Cambridge -AP
Biotech

Sarepta gene therapy improves muscle function for patients with rare limb-girdle disease

By Adam Feuerstein

Dr Ben Davies
Biotech

‘It’s really a horrific situation’: What one doctor thinks about drug shortages‚ and how to solve them

By Adam Feuerstein, Damian Garde, and Rebecca Robbins

Play
The Readout LOUD

Listen: Congressional paralysis, drug shortages, & biotech’s foul mood

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Biotech

Sarepta under new pressure as a competitor files with FDA for Duchenne drug

By Adam Feuerstein

Wonka's golden ticket
Biotech

They got Pfizer’s ‘Golden Ticket.’ Did it live up to the hype?

By Kate Sheridan

Al Sandrock Biogen
Biotech

At Biogen, drug developer Al Sandrock gets a chance to take his shot

By Matthew Herper

LabCentral Rendering
Biotech

Biotech incubator LabCentral to double its space in Boston

By Jonathan Saltzman — Boston Globe

Scorecard
Biotech

The biotech scorecard for the fourth quarter: 13 stock-moving events to watch

By Adam Feuerstein

Vertex Pharmaceuticals Inc. building
Biotech

Vertex takes on Huntington’s disease in deal with Ribometrix

By Jonathan Saltzman — Boston Globe

human colon cancer cells
Biotech

Amgen’s KRAS-blocking drug shows minimal effect in colon cancer patients

By Adam Feuerstein

Play
The Readout LOUD

Listen: Vaping upheaval, DNA test dynamics, & the future of genome editing

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Biotech

Moderna will give Harvard researchers access to its RNA technology

By Kate Sheridan

Pharmalot

Novartis unit says FDA wasn’t told of data manipulation sooner because it was ‘highly complex’

By Ed Silverman

Executive empty seat
Biotech

Akcea, a biotech that relies on gene-blocking tech, loses its three top executives in one fell swoop

By Kate Sheridan

biotech invest
Biotech

RA Capital launches Carnot, an incubator for early-stage biotechs

By Kate Sheridan

Play
The Readout LOUD

Listen: Unicorn growth spurts, Amgen’s future, & mice on Twitter

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Silhouetted people
Biotech

Amid privacy concerns, startup becomes first consumer DNA company to offer anonymous sequencing

By Sharon Begley

Ginkgo Bioworks 06
Biotech

Ginkgo Bioworks scores an eye-popping valuation with latest fundraise

By Jonathan Saltzman — Boston Globe

Tumor Bandolier
Biotech

A biotech startup hopes to disarm cancer by targeting a genetic bandolier

By Damian Garde

Business

Martin Shkreli’s drug company is losing money — and its salesforce feels cheated

By Adam Feuerstein

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy